431 related articles for article (PubMed ID: 36892839)
1. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada.
Sumner MW; Xie J; Zemek R; Winston K; Freire G; Burstein B; Kam A; Emsley J; Gravel J; Porter R; Sabhaney V; Mater A; Salvadori MI; Berthelot S; Beer D; Poonai N; Moffatt A; Wright B; Freedman SB;
JAMA Netw Open; 2023 Mar; 6(3):e232328. PubMed ID: 36892839
[TBL] [Abstract][Full Text] [Related]
2. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments: The Global PERN-COVID-19 Study.
Funk AL; Florin TA; Kuppermann N; Tancredi DJ; Xie J; Kim K; Neuman MI; Ambroggio L; Plint AC; Mintegi S; Klassen TP; Salvadori MI; Malley R; Payne DC; Simon NJ; Yock-Corrales A; Nebhrajani JR; Chaudhari PP; Breslin KA; Finkelstein Y; Campos C; Bergmann KR; Bhatt M; Ahmad FA; Gardiner MA; Avva UR; Shah NP; Sartori LF; Sabhaney VJ; Caperell K; Navanandan N; Borland ML; Morris CR; Gangoiti I; Pavlicich V; Kannikeswaran N; Lunoe MM; Rino PB; Kam AJ; Cherry JC; Rogers AJ; Chong SL; Palumbo L; Angelats CM; Morrison AK; Kwok MY; Becker SM; Dixon AC; Poonai N; Eckerle M; Wassem M; Dalziel SR; Freedman SB;
JAMA Netw Open; 2022 Jan; 5(1):e2142322. PubMed ID: 35015063
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
[TBL] [Abstract][Full Text] [Related]
6. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.
Funk AL; Kuppermann N; Florin TA; Tancredi DJ; Xie J; Kim K; Finkelstein Y; Neuman MI; Salvadori MI; Yock-Corrales A; Breslin KA; Ambroggio L; Chaudhari PP; Bergmann KR; Gardiner MA; Nebhrajani JR; Campos C; Ahmad FA; Sartori LF; Navanandan N; Kannikeswaran N; Caperell K; Morris CR; Mintegi S; Gangoiti I; Sabhaney VJ; Plint AC; Klassen TP; Avva UR; Shah NP; Dixon AC; Lunoe MM; Becker SM; Rogers AJ; Pavlicich V; Dalziel SR; Payne DC; Malley R; Borland ML; Morrison AK; Bhatt M; Rino PB; Beneyto Ferre I; Eckerle M; Kam AJ; Chong SL; Palumbo L; Kwok MY; Cherry JC; Poonai N; Waseem M; Simon NJ; Freedman SB;
JAMA Netw Open; 2022 Jul; 5(7):e2223253. PubMed ID: 35867061
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 Condition in Children 6 and 12 Months After Infection.
Dun-Dery F; Xie J; Winston K; Burstein B; Gravel J; Emsley J; Sabhaney V; Zemek R; Berthelot S; Beer D; Kam A; Freire G; Mater A; Porter R; Poonai N; Moffatt A; Dixon A; Salvadori MI; Freedman SB;
JAMA Netw Open; 2023 Dec; 6(12):e2349613. PubMed ID: 38153737
[TBL] [Abstract][Full Text] [Related]
8. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.
Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F
Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
Smith H; Mahon A; Moss A; Rao S
J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
[TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
11. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
12. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
[TBL] [Abstract][Full Text] [Related]
13. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
Portmann L; de Kraker MEA; Fröhlich G; Thiabaud A; Roelens M; Schreiber PW; Troillet N; Iten A; Widmer A; Harbarth S; Sommerstein R;
JAMA Netw Open; 2023 Feb; 6(2):e2255599. PubMed ID: 36790812
[TBL] [Abstract][Full Text] [Related]
14. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
15. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
16. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
Lo Vecchio A; Garazzino S; Smarrazzo A; Venturini E; Poeta M; Berlese P; Denina M; Meini A; Bosis S; Galli L; Cazzato S; Nicolini G; Vergine G; Giacchero R; Ballardini G; Dodi I; Salvini FM; Manzoni P; Ferrante G; Quadri V; Campana A; Badolato R; Villani A; Guarino A; Gattinara GC;
JAMA Netw Open; 2021 Dec; 4(12):e2139974. PubMed ID: 34928354
[TBL] [Abstract][Full Text] [Related]
18. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
[TBL] [Abstract][Full Text] [Related]
19. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
[TBL] [Abstract][Full Text] [Related]
20. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
